Patents by Inventor Guorong Li

Guorong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180234873
    Abstract: A method for operating a transmitting device includes receiving a first packet data convergence protocol (PDCP) protocol data unit (PDU) associated with a first remote device (RD), the first PDCP PDU including at least a first PDCP header, generating a first nested PDCP PDU in accordance with the first PDCP PDU, the first nested PDCP PDU including a second PDCP header and the first PDCP PDU, the second PDCP header comprising a first PDU type indicator indicating that the first nested PDCP PDU includes a first relayed PDCP PDU and a first identifier associated with the first RD, and sending the first nested PDCP PDU on a radio bearer.
    Type: Application
    Filed: April 17, 2018
    Publication date: August 16, 2018
    Inventors: Nathan Edward Tenny, Da Wang, Guowei Ouyang, Hui Jin, Guorong Li
  • Patent number: 9986456
    Abstract: A method for operating a transmitting device includes receiving a first packet data convergence protocol (PDCP) protocol data unit (PDU) associated with a first remote device (RD), the first PDCP PDU including at least a first PDCP header, generating a first nested PDCP PDU in accordance with the first PDCP PDU, the first nested PDCP PDU including a second PDCP header and the first PDCP PDU, the second PDCP header comprising a first PDU type indicator indicating that the first nested PDCP PDU includes a first relayed PDCP PDU and a first identifier associated with the first RD, and sending the first nested PDCP PDU on a radio bearer.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: May 29, 2018
    Assignee: FUTUREWEI TECHNOLOGIES, INC.
    Inventors: Nathan Edward Tenny, Da Wang, Guowei Ouyang, Hui Jin, Guorong Li
  • Publication number: 20180007626
    Abstract: A method for paging a user equipment (UE) includes receiving a generic page indication for the UE, the generic page indication including a list of radio access networks (RANs), selecting a subset of the list of RANs, sending a RAN-specific page indication for each RAN in the subset of the list of RANs, receiving a first RAN-specific page response associated with the UE, and sending a generic page response corresponding to the first RAN-specific page response.
    Type: Application
    Filed: May 25, 2017
    Publication date: January 4, 2018
    Inventors: Nathan Edward Tenny, Xiaoyan Duan, Hui Jin, Guorong Li, Guowei Ouyang, Yunsong Yang
  • Publication number: 20170353883
    Abstract: A method for operating a transmitting device includes receiving a first packet data convergence protocol (PDCP) protocol data unit (PDU) associated with a first remote device (RD), the first PDCP PDU including at least a first PDCP header, generating a first nested PDCP PDU in accordance with the first PDCP PDU, the first nested PDCP PDU including a second PDCP header and the first PDCP PDU, the second PDCP header comprising a first PDU type indicator indicating that the first nested PDCP PDU includes a first relayed PDCP PDU and a first identifier associated with the first RD, and sending the first nested PDCP PDU on a radio bearer.
    Type: Application
    Filed: June 3, 2016
    Publication date: December 7, 2017
    Inventors: Nathan Edward Tenny, Da Wang, Guowei Ouyang, Hui Jin, Guorong Li
  • Publication number: 20170332425
    Abstract: A method for establishing relay services includes transmitting a random access parameter to a network node indicating a request for relaying services, the transmitting of the random access parameter initiates a first random access procedure, receiving, by the RD, a random access response including a relay indicator indicating one or more candidate relay devices, wherein receiving the relay indicator terminates the first random access procedure, and searching for a relay device in accordance with the relay indicator included in the random access response.
    Type: Application
    Filed: April 10, 2017
    Publication date: November 16, 2017
    Inventors: Nathan Edward Tenny, Guorong Li
  • Publication number: 20170325268
    Abstract: A method of performing a random access procedure includes randomly selecting a backoff time from within a backoff window ranging from o to a specified multiple of a random access preamble unit, waiting until a time initialized with the backoff time expires, and retransmitting a random access preamble.
    Type: Application
    Filed: July 26, 2017
    Publication date: November 9, 2017
    Inventors: Bin Liu, Yongbo Zeng, Jian Wang, Guorong Li, Yu Cai
  • Publication number: 20170265230
    Abstract: A method of performing a random access procedure includes randomly selecting a backoff time from within a backoff window ranging from 0 to a specified multiple of a random access preamble unit, waiting until a time initialized with the backoff time expires, and retransmitting a random access preamble.
    Type: Application
    Filed: March 7, 2017
    Publication date: September 14, 2017
    Inventors: Bin Liu, Yongbo Zeng, Jian Wang, Guorong Li, Yu Cai
  • Patent number: 9498511
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Grant
    Filed: July 3, 2014
    Date of Patent: November 22, 2016
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng
  • Publication number: 20140315785
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Application
    Filed: July 3, 2014
    Publication date: October 23, 2014
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng
  • Patent number: 8796302
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: August 5, 2014
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng
  • Publication number: 20120142615
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Application
    Filed: December 13, 2011
    Publication date: June 7, 2012
    Applicants: Human Service
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng
  • Patent number: 8088787
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Grant
    Filed: May 12, 2005
    Date of Patent: January 3, 2012
    Assignee: The United States of America as represented by the Secretary, Department of Health and Human Services
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng
  • Publication number: 20110171643
    Abstract: A method or process for the diagnosis/prognosis/follow-up of cancer in vertebrates, comprising the following steps: i) extracting nucleic material from a biological sample; ii) using at least one pair of amplification primers in order to obtain amplicons of at least one target sequence; iii) using at least one detection probe for detecting the presence of the said amplicons; characterised in that the extraction step is carried out from extracellular nucleic material from a biological sample. More precisely, the said nucleic material is RNA or DNA of the CA9 gene circulating in the free state in a biological sample. The invention also relates to the pairs of amplification primers and/or a detection probe for the diagnosis/prognosis/follow-up of cancer including at least 15 nucleotide patterns of a nucleotide sequence selected from the SEQ ID nos. 1 to 6, and a kit including the said at least one pair of primers and/or at least the said probe.
    Type: Application
    Filed: March 9, 2009
    Publication date: July 14, 2011
    Applicants: Chu Saint Etienne Chu-Hopital Nord, Universite Jean Monnet
    Inventors: Guorong LI, Jacques Tostain, Christian Genin
  • Publication number: 20080038199
    Abstract: The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof; opioid peptides; a peptide comprising the tripeptide GGF; and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
    Type: Application
    Filed: May 12, 2005
    Publication date: February 14, 2008
    Applicants: The Government of the United States as represented, by The Secretary Department of Health and Human Services
    Inventors: Jau-Shyong Hong, Liya Qin, Guorong Li, Michelle Block, Wei Zhang, Po-See Chen, Giia-Shuen Peng